|
Real-time
Euronext Paris
18:43:41 03/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.7800 EUR | -0.89% |
|
-3.35% | +12.39% |
| 07-22 | Valbiotis Publishes Results of Reverse-It Clinical Study Evaluating Totum 63 in Nature Communications | CI |
| 06-29 | Valbiotis Raises EUR10 Million for Commercial Development, Working Capital | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VALBIOTIS | Bio Therapeutic Drugs | -0.89% | -3.35% | +12.39% | -5.80% | -88.61% | 21.58M |  |  | |
- Stock Market
- Stocks
- ALVAL Stock
- Charts Valbiotis
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
